Global Adalimumab Biosimilar Sales Market Report 2017

October 2017 | 116 pages | ID: G2F700C07E0EN
QYResearch

Abstracts

In this report, the global Adalimumab Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Adalimumab Biosimilar for these regions, from 2012 to 2022 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Adalimumab Biosimilar market competition by top manufacturers/players, with Adalimumab Biosimilar sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AET BioTech
• Amgen
• Boehringer Ingelheim
• Coherus Biosciences
• Fujifilm Kyowa Kirin Biologics
• LG Life Sciences/Mochida Pharmaceutical
• Momenta Pharmaceuticals
• Oncobiologics
• Pfizer
• Samsung Bioepsis
• Sandoz
• Zydus Cadila

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Tablet
• Oral Solution

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Adalimumab Biosimilar for each application, including

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Adalimumab Biosimilar Sales Market Report 2017

1 ADALIMUMAB BIOSIMILAR MARKET OVERVIEW

1.1 Product Overview and Scope of Adalimumab Biosimilar
1.2 Classification of Adalimumab Biosimilar by Product Category
  1.2.1 Global Adalimumab Biosimilar Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Adalimumab Biosimilar Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Tablet
  1.2.4 Oral Solution
1.3 Global Adalimumab Biosimilar Market by Application/End Users
  1.3.1 Global Adalimumab Biosimilar Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
1.4 Global Adalimumab Biosimilar Market by Region
  1.4.1 Global Adalimumab Biosimilar Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Adalimumab Biosimilar Status and Prospect (2012-2022)
  1.4.3 China Adalimumab Biosimilar Status and Prospect (2012-2022)
  1.4.4 Europe Adalimumab Biosimilar Status and Prospect (2012-2022)
  1.4.5 Japan Adalimumab Biosimilar Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Adalimumab Biosimilar Status and Prospect (2012-2022)
  1.4.7 India Adalimumab Biosimilar Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Adalimumab Biosimilar (2012-2022)
  1.5.1 Global Adalimumab Biosimilar Sales and Growth Rate (2012-2022)
  1.5.2 Global Adalimumab Biosimilar Revenue and Growth Rate (2012-2022)

2 GLOBAL ADALIMUMAB BIOSIMILAR COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Adalimumab Biosimilar Market Competition by Players/Suppliers
  2.1.1 Global Adalimumab Biosimilar Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Adalimumab Biosimilar Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Adalimumab Biosimilar (Volume and Value) by Type
  2.2.1 Global Adalimumab Biosimilar Sales and Market Share by Type (2012-2017)
  2.2.2 Global Adalimumab Biosimilar Revenue and Market Share by Type (2012-2017)
2.3 Global Adalimumab Biosimilar (Volume and Value) by Region
  2.3.1 Global Adalimumab Biosimilar Sales and Market Share by Region (2012-2017)
  2.3.2 Global Adalimumab Biosimilar Revenue and Market Share by Region (2012-2017)
2.4 Global Adalimumab Biosimilar (Volume) by Application

3 UNITED STATES ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

3.1 United States Adalimumab Biosimilar Sales and Value (2012-2017)
  3.1.1 United States Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  3.1.2 United States Adalimumab Biosimilar Revenue and Growth Rate (2012-2017)
  3.1.3 United States Adalimumab Biosimilar Sales Price Trend (2012-2017)
3.2 United States Adalimumab Biosimilar Sales Volume and Market Share by Players
3.3 United States Adalimumab Biosimilar Sales Volume and Market Share by Type
3.4 United States Adalimumab Biosimilar Sales Volume and Market Share by Application

4 CHINA ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

4.1 China Adalimumab Biosimilar Sales and Value (2012-2017)
  4.1.1 China Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  4.1.2 China Adalimumab Biosimilar Revenue and Growth Rate (2012-2017)
  4.1.3 China Adalimumab Biosimilar Sales Price Trend (2012-2017)
4.2 China Adalimumab Biosimilar Sales Volume and Market Share by Players
4.3 China Adalimumab Biosimilar Sales Volume and Market Share by Type
4.4 China Adalimumab Biosimilar Sales Volume and Market Share by Application

5 EUROPE ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Adalimumab Biosimilar Sales and Value (2012-2017)
  5.1.1 Europe Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  5.1.2 Europe Adalimumab Biosimilar Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Adalimumab Biosimilar Sales Price Trend (2012-2017)
5.2 Europe Adalimumab Biosimilar Sales Volume and Market Share by Players
5.3 Europe Adalimumab Biosimilar Sales Volume and Market Share by Type
5.4 Europe Adalimumab Biosimilar Sales Volume and Market Share by Application

6 JAPAN ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Adalimumab Biosimilar Sales and Value (2012-2017)
  6.1.1 Japan Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  6.1.2 Japan Adalimumab Biosimilar Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Adalimumab Biosimilar Sales Price Trend (2012-2017)
6.2 Japan Adalimumab Biosimilar Sales Volume and Market Share by Players
6.3 Japan Adalimumab Biosimilar Sales Volume and Market Share by Type
6.4 Japan Adalimumab Biosimilar Sales Volume and Market Share by Application

7 SOUTHEAST ASIA ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Adalimumab Biosimilar Sales and Value (2012-2017)
  7.1.1 Southeast Asia Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Adalimumab Biosimilar Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Adalimumab Biosimilar Sales Price Trend (2012-2017)
7.2 Southeast Asia Adalimumab Biosimilar Sales Volume and Market Share by Players
7.3 Southeast Asia Adalimumab Biosimilar Sales Volume and Market Share by Type
7.4 Southeast Asia Adalimumab Biosimilar Sales Volume and Market Share by Application

8 INDIA ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

8.1 India Adalimumab Biosimilar Sales and Value (2012-2017)
  8.1.1 India Adalimumab Biosimilar Sales and Growth Rate (2012-2017)
  8.1.2 India Adalimumab Biosimilar Revenue and Growth Rate (2012-2017)
  8.1.3 India Adalimumab Biosimilar Sales Price Trend (2012-2017)
8.2 India Adalimumab Biosimilar Sales Volume and Market Share by Players
8.3 India Adalimumab Biosimilar Sales Volume and Market Share by Type
8.4 India Adalimumab Biosimilar Sales Volume and Market Share by Application

9 GLOBAL ADALIMUMAB BIOSIMILAR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 AET BioTech
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Adalimumab Biosimilar Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 AET BioTech Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Amgen
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Adalimumab Biosimilar Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Amgen Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Boehringer Ingelheim
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Adalimumab Biosimilar Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Boehringer Ingelheim Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Coherus Biosciences
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Adalimumab Biosimilar Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Coherus Biosciences Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Fujifilm Kyowa Kirin Biologics
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Adalimumab Biosimilar Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 LG Life Sciences/Mochida Pharmaceutical
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Adalimumab Biosimilar Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Momenta Pharmaceuticals
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Adalimumab Biosimilar Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Oncobiologics
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Adalimumab Biosimilar Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Oncobiologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Pfizer
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Adalimumab Biosimilar Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Pfizer Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Samsung Bioepsis
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Adalimumab Biosimilar Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Samsung Bioepsis Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Sandoz
9.12 Zydus Cadila

10 ADALIMUMAB BIOSIMILAR MAUFACTURING COST ANALYSIS

10.1 Adalimumab Biosimilar Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Adalimumab Biosimilar
10.3 Manufacturing Process Analysis of Adalimumab Biosimilar

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Adalimumab Biosimilar Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL ADALIMUMAB BIOSIMILAR MARKET FORECAST (2017-2022)

14.1 Global Adalimumab Biosimilar Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Adalimumab Biosimilar Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Adalimumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Adalimumab Biosimilar Price and Trend Forecast (2017-2022)
14.2 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Adalimumab Biosimilar Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Adalimumab Biosimilar Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Adalimumab Biosimilar Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Adalimumab Biosimilar Sales Forecast by Type (2017-2022)
  14.3.2 Global Adalimumab Biosimilar Revenue Forecast by Type (2017-2022)
  14.3.3 Global Adalimumab Biosimilar Price Forecast by Type (2017-2022)
14.4 Global Adalimumab Biosimilar Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Adalimumab Biosimilar
Figure Global Adalimumab Biosimilar Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Adalimumab Biosimilar Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablet Product Picture
Figure Oral Solution Product Picture
Figure Global Adalimumab Biosimilar Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Adalimumab Biosimilar by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure Global Adalimumab Biosimilar Market Size (Million USD) by Regions (2012-2022)
Figure United States Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Adalimumab Biosimilar Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Adalimumab Biosimilar Sales Volume (K Units) (2012-2017)
Table Global Adalimumab Biosimilar Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Adalimumab Biosimilar Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Adalimumab Biosimilar Sales Share by Players/Suppliers
Figure 2017 Adalimumab Biosimilar Sales Share by Players/Suppliers
Figure Global Adalimumab Biosimilar Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Adalimumab Biosimilar Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Adalimumab Biosimilar Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Adalimumab Biosimilar Revenue Share by Players
Table 2017 Global Adalimumab Biosimilar Revenue Share by Players
Table Global Adalimumab Biosimilar Sales (K Units) and Market Share by Type (2012-2017)
Table Global Adalimumab Biosimilar Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Adalimumab Biosimilar by Type (2012-2017)
Figure Global Adalimumab Biosimilar Sales Growth Rate by Type (2012-2017)
Table Global Adalimumab Biosimilar Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Adalimumab Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Adalimumab Biosimilar by Type (2012-2017)
Figure Global Adalimumab Biosimilar Revenue Growth Rate by Type (2012-2017)
Table Global Adalimumab Biosimilar Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Adalimumab Biosimilar Sales Share by Region (2012-2017)
Figure Sales Market Share of Adalimumab Biosimilar by Region (2012-2017)
Figure Global Adalimumab Biosimilar Sales Growth Rate by Region in 2016
Table Global Adalimumab Biosimilar Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Adalimumab Biosimilar Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Adalimumab Biosimilar by Region (2012-2017)
Figure Global Adalimumab Biosimilar Revenue Growth Rate by Region in 2016
Table Global Adalimumab Biosimilar Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Adalimumab Biosimilar Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Adalimumab Biosimilar by Region (2012-2017)
Figure Global Adalimumab Biosimilar Revenue Market Share by Region in 2016
Table Global Adalimumab Biosimilar Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Adalimumab Biosimilar Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Adalimumab Biosimilar by Application (2012-2017)
Figure Global Adalimumab Biosimilar Sales Market Share by Application (2012-2017)
Figure United States Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure United States Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Adalimumab Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table United States Adalimumab Biosimilar Sales Volume (K Units) by Players (2012-2017)
Table United States Adalimumab Biosimilar Sales Volume Market Share by Players (2012-2017)
Figure United States Adalimumab Biosimilar Sales Volume Market Share by Players in 2016
Table United States Adalimumab Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table United States Adalimumab Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure United States Adalimumab Biosimilar Sales Volume Market Share by Type in 2016
Table United States Adalimumab Biosimilar Sales Volume (K Units) by Application (2012-2017)
Table United States Adalimumab Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure United States Adalimumab Biosimilar Sales Volume Market Share by Application in 2016
Figure China Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure China Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Adalimumab Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table China Adalimumab Biosimilar Sales Volume (K Units) by Players (2012-2017)
Table China Adalimumab Biosimilar Sales Volume Market Share by Players (2012-2017)
Figure China Adalimumab Biosimilar Sales Volume Market Share by Players in 2016
Table China Adalimumab Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table China Adalimumab Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure China Adalimumab Biosimilar Sales Volume Market Share by Type in 2016
Table China Adalimumab Biosimilar Sales Volume (K Units) by Application (2012-2017)
Table China Adalimumab Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure China Adalimumab Biosimilar Sales Volume Market Share by Application in 2016
Figure Europe Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Adalimumab Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Adalimumab Biosimilar Sales Volume (K Units) by Players (2012-2017)
Table Europe Adalimumab Biosimilar Sales Volume Market Share by Players (2012-2017)
Figure Europe Adalimumab Biosimilar Sales Volume Market Share by Players in 2016
Table Europe Adalimumab Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table Europe Adalimumab Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure Europe Adalimumab Biosimilar Sales Volume Market Share by Type in 2016
Table Europe Adalimumab Biosimilar Sales Volume (K Units) by Application (2012-2017)
Table Europe Adalimumab Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure Europe Adalimumab Biosimilar Sales Volume Market Share by Application in 2016
Figure Japan Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Adalimumab Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Adalimumab Biosimilar Sales Volume (K Units) by Players (2012-2017)
Table Japan Adalimumab Biosimilar Sales Volume Market Share by Players (2012-2017)
Figure Japan Adalimumab Biosimilar Sales Volume Market Share by Players in 2016
Table Japan Adalimumab Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table Japan Adalimumab Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure Japan Adalimumab Biosimilar Sales Volume Market Share by Type in 2016
Table Japan Adalimumab Biosimilar Sales Volume (K Units) by Application (2012-2017)
Table Japan Adalimumab Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure Japan Adalimumab Biosimilar Sales Volume Market Share by Application in 2016
Figure Southeast Asia Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Adalimumab Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Adalimumab Biosimilar Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Adalimumab Biosimilar Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Adalimumab Biosimilar Sales Volume Market Share by Players in 2016
Table Southeast Asia Adalimumab Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Adalimumab Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Adalimumab Biosimilar Sales Volume Market Share by Type in 2016
Table Southeast Asia Adalimumab Biosimilar Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Adalimumab Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Adalimumab Biosimilar Sales Volume Market Share by Application in 2016
Figure India Adalimumab Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure India Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Adalimumab Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table India Adalimumab Biosimilar Sales Volume (K Units) by Players (2012-2017)
Table India Adalimumab Biosimilar Sales Volume Market Share by Players (2012-2017)
Figure India Adalimumab Biosimilar Sales Volume Market Share by Players in 2016
Table India Adalimumab Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table India Adalimumab Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure India Adalimumab Biosimilar Sales Volume Market Share by Type in 2016
Table India Adalimumab Biosimilar Sales Volume (K Units) by Application (2012-2017)
Table India Adalimumab Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure India Adalimumab Biosimilar Sales Volume Market Share by Application in 2016
Table AET BioTech Basic Information List
Table AET BioTech Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AET BioTech Adalimumab Biosimilar Sales Growth Rate (2012-2017)
Figure AET BioTech Adalimumab Biosimilar Sales Global Market Share (2012-2017
Figure AET BioTech Adalimumab Biosimilar Revenue Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Adalimumab Biosimilar Sales Growth Rate (2012-2017)
Figure Amgen Adalimumab Biosimilar Sales Global Market Share (2012-2017
Figure Amgen Adalimumab Biosimilar Revenue Global Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Adalimumab Biosimilar Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Adalimumab Biosimilar Sales Global Market Share (2012-2017
Figure Boehringer Ingelheim Adalimumab Biosimilar Revenue Global Market Share (2012-2017)
Table Coherus Biosciences Basic Information List
Table Coherus Biosciences Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Coherus Biosciences Adalimumab Biosimilar Sales Growth Rate (2012-2017)
Figure Coherus Biosciences Adalimumab Biosimilar Sales Global Market Share (2012-2017
Figure Coherus Biosciences Adalimumab Biosimilar Revenue Global Market Share (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales Growth Rate (2012-2017)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales Global Market Share (2012-2017
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Revenue Global Market Share (2012-2017)
Table LG Life Sciences/Mochida Pharmaceutical Basic Information List
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales Growth Rate (2012-2017)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales Global Market Share (2012-2017
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Revenue Global Market Share (2012-2017)
Table Momenta Pharmaceuticals Basic Information List
Table Momenta Pharmaceuticals Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Sales Growth Rate (2012-2017)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Sales Global Market Share (2012-2017
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Revenue Global Market Share (2012-2017)
Table Oncobiologics Basic Information List
Table Oncobiologics Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Oncobiologics Adalimumab Biosimilar Sales Growth Rate (2012-2017)
Figure Oncobiologics Adalimumab Biosimilar Sales Global Market Share (2012-2017
Figure Oncobiologics Adalimumab Biosimilar Revenue Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Adalimumab Biosimilar Sales Growth Rate (2012-2017)
Figure Pfizer Adalimumab Biosimilar Sales Global Market Share (2012-2017
Figure Pfizer Adalimumab Biosimilar Revenue Global Market Share (2012-2017)
Table Samsung Bioepsis Basic Information List
Table Samsung Bioepsis Adalimumab Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Samsung Bioepsis Adalimumab Biosimilar Sales Growth Rate (2012-2017)
Figure Samsung Bioepsis Adalimumab Biosimilar Sales Global Market Share (2012-2017
Figure Samsung Bioepsis Adalimumab Biosimilar Revenue Global Market Share (2012-2017)
Table Sandoz Basic Information List
Table Zydus Cadila Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adalimumab Biosimilar
Figure Manufacturing Process Analysis of Adalimumab Biosimilar
Figure Adalimumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Adalimumab Biosimilar Major Players in 2016
Table Major Buyers of Adalimumab Biosimilar
Table Distributors/Traders List
Figure Global Adalimumab Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Adalimumab Biosimilar Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Adalimumab Biosimilar Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume Market Share Forecast by Regions in 2022
Table Global Adalimumab Biosimilar Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Adalimumab Biosimilar Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Adalimumab Biosimilar Revenue Market Share Forecast by Regions in 2022
Figure United States Adalimumab Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Adalimumab Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Adalimumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Adalimumab Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Adalimumab Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Adalimumab Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Adalimumab Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Adalimumab Biosimilar Sales (K Units) Forecast by Type (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Adalimumab Biosimilar Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Adalimumab Biosimilar Revenue Market Share Forecast by Type (2017-2022)
Table Global Adalimumab Biosimilar Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Adalimumab Biosimilar Sales (K Units) Forecast by Application (2017-2022)
Figure Global Adalimumab Biosimilar Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources